Sign inCreate account

Report workspace tools

NCT00979342COMPLETEDanonymous

Interlace Medical Comparative Sedation Study

Sponsor

Source record

Hologic, Inc.

Phase

Source record

NA

Modality

AI-normalized

cell therapy

Target

AI-normalized

Hysteroscopic Morcellator

Indication / condition

AI-normalized

Uterine Fibroids

Intervention

Source record

Hysteroscopic Morcellator

Source & freshness

Source record

NCT ID

NCT00979342

Original source

ClinicalTrials.gov

Source last updated

Jul 23, 2010

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT00979342

Title

Interlace Medical Comparative Sedation Study

Sponsor

Hologic, Inc.

Status

COMPLETED

Phase

NA

Condition raw

Uterine Fibroids, Polyps

Condition normalized

Uterine Fibroids, Polyps

Modality raw

cell therapy

Modality normalized

cell therapy

Target raw

Hysteroscopic Morcellator

Target normalized

Hysteroscopic Morcellator

Interventions

Hysteroscopic Morcellator

Public preview

Source record

The purpose of this study is to develop a recommended local anesthetic protocol and post-treatment pain management regimen, in order to assure patient comfort during office-based treatment with the MyoSure Hysteroscopic Tissue Removal Device. Subject self-reported pain scores (as rated on an 11 point scale) will be compared at multiple time intervals between all treatment groups.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Interlace Medical Comparative Sedation Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT00979342

Status

COMPLETED

Phase

NA

Sponsor

Hologic, Inc.

Executive brief

Investment-Ready Snapshot

The purpose of this study is to develop a recommended local anesthetic protocol and post-treatment pain management regimen, in order to assure patient comfort during office-based treatment with the MyoSure Hysteroscopic Tissue Removal Device. Subject self-reported pain scores (as rated on an 11 point scale) will be compared at multiple time intervals between all treatment groups.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedJul 23, 2010
Internal syncJun 09, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00979342

Indication

Uterine Fibroids

Modality

cell therapy

Target

Hysteroscopic Morcellator

Intervention

Hysteroscopic Morcellator

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.